Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder
This study has been completed.
Sponsor:
University of Medicine and Dentistry New Jersey
Collaborator:
AstraZeneca
Information provided by:
University of Medicine and Dentistry New Jersey
ClinicalTrials.gov Identifier:
NCT00122070
First received: July 15, 2005
Last updated: June 9, 2008
Last verified: June 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2008 |
| Primary Completion Date: | September 2007 (Final data collection date for primary outcome measure) |